Post-prandial iron absorption in humans: Comparison between HFE genotypes and iron deficiency anaemia

Clinical Nutrition

Volumn 27, Issue 2, 2008, Pages 258-263

  Hutchinson, Carol ^a   Conway, Rana E ^a   Bomford, Adrian ^a   Hider, Robert C ^a   Powell, Jonathan J ^b   Geissler, Catherine A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

Author keywords

Anaemia; HFE C282Y; Non transferrin bound iron; NTBI; Serum iron increase

Indexed keywords

FERRITIN; HFE PROTEIN; IRON; TRACER; TRANSFERRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; MALE; POSTPRANDIAL STATE;

ADULT; ANEMIA, IRON-DEFICIENCY; AREA UNDER CURVE; FEMALE; FERRITINS; GENOTYPE; HEMOCHROMATOSIS; HEMOGLOBINS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTESTINAL ABSORPTION; IRON; IRON ISOTOPES; IRON, DIETARY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; POSTPRANDIAL PERIOD;

EID: 41349111434     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2007.12.007     Document Type: Article

References (34)

1. Lynch S.R., Skikne B.S., and Cook J.D. Food iron absorption in idiopathic hemochromatosis. Blood 74 (1989) 2187-2193
2. Hunt J.R., and Zeng H. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Am J Clin Nutr 80 (2004) 924-931
3. Roe M.A., Heath A.L., Oyston S.L., et al. Iron absorption in male C282Y heterozygotes. Am J Clin Nutr 81 (2005) 814-821
4. Ricketts C., Cavill I., Napier J.A., and Jacobs A. Ferrokinetics and erythropoiesis in man: an evaluation of ferrokinetic measurements. Br J Haematol 35 (1977) 41-47
5. Hoppe M., and Hulthen L. Validation of the clinical approach of using the induced serum iron increase after 1 h as a measure of iron absorption. Clin Nutr 25 (2006) 163-165
6. Hoppe M., Hulthen L., and Hallberg L. The validation of using serum iron increase to measure iron absorption in human subjects. Br J Nutr 92 (2004) 485-488
7. Conway R.E., Geissler C.A., Hider R.C., Thompson R.P.H., and Powell J.J. Measurement of dietary iron bioavailability using serum iron curves. J Nutr 136 (2006) 1910-1914
8. Hutchinson C., Al-Ashgar W., Liu D.Y., Hider R.C., Powell J.J., and Geissler C. Oral ferrous sulfate leads to a marked increase in circulating levels of pro-oxidant non-transferrin bound iron. Eur J Clin Invest 34 (2004) 782-784
9. Mackey D.G., and Seal U.S. The detection of four molecular forms of human transferrin using the iron binding process. Biochim Biophys Acta 453 (1976) 250-256
10. Mullighan C.G., Bunce M., Fanning G.C., Marshall S.E., and Welsh K.I. A rapid method of haplotyping HFE mutations and linkage disequilibrium in a Caucasoid population. Gut 42 (1998) 566-569
11. Gosriwatana I., Loreal O., Lu S., Brissot P., Porter J., and Hider R.C. Quantification of non-transferrin bound iron in the presence of unsaturated transferrin. Anal Biochem 273 (1999) 212-220
12. Breuer W., Ronson A., Slotki I.N., Abramov A., Hershko C., and Cabanchik Z.I. The assessment of serum non-transferrin bound iron in chelation therapy and iron supplementation. Blood 95 (2000) 2975-2982
13. Loreal O., Gosriwatana I., Guyader D., Porter J., Brissot P., and Hider R.C. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol 32 (2000) 727-733
14. Vanhaecke F., Balcaen L., De Wannemacker G., and Moens L. Capabilities of inductively coupled plasma mass spectrometry for the measurement of Fe isotope ratios. J Anal At Spectrom 17 (2002) 933-943
15. Dainty J.R., Roe M.A., Teucher B., Eagles J., and Fairweather-Tait S.J. Quantification of unlabelled non-haem iron absorption in human subjects: a pilot study. Br J Nutr 90 (2003) 503-506
16. Powell L.W., Campbell C.W., and Wilson E. Intestinal mucosal uptake of iron and iron retention in idiopathic haemochromatosis as evidence for a mucosal abnormality. Gut 11 (1970) 727-731
17. Hutchinson C., Geissler C., Powell J., and Bomford A. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut 56 (2007) 1291-1295
18. Cook J.D., Marsaglia G., Eschbach J.W., Funk D.D., and Finch C.A. Ferrokinetics: a biological model for plasma iron exchange in man. J Clin Invest 49 (1970) 197-205
19. Gunshin H., Mackenzie B., Berger U.V., et al. Cloning and characterisation of a mammalian proton-coupled metal-ion transporter. Nature 388 (1997) 482-488
20. Donovan A., Brownlie A., Zhou Y., et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403 (2000) 776-781
21. Zoller H., Koch R.O., Theurl I., et al. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 120 (2001) 1412-1419
22. Stuart K.A., Anderson G.J., Frazer D.M., et al. Duodenal expression of iron transport molecules in untreated haemochromatosis subjects. Gut 52 (2003) 953-959
23. Kelleher T., Ryan E., Barrett S., et al. Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis. Gut 53 (2004) 1174-1179
24. Cazzola M., Huebers H.A., Sayers M.H., MacPhai P., Eng M., and Finch C.A. Transferrin saturation, plasma iron turnover, and transferrin uptake in normal humans. Blood 66 (1985) 935-939
25. McLaren G.D., Nathanson M.H., Jacobs A., Trevett D., and Thomson W. Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis. J Lab Clin Med 117 (1991) 390-391
26. Brissot P., Wright T.L., Ma W.L., and Weisiger R.A. Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states. J Clin Invest 76 (1985) 1463-1470
27. Datz C., Haas T., Rinner H., Sandhofer F., Patsch W., and Paulweber B. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency?. Clin Chem 44 (1998) 2429-2432
28. Burt M.J., George P.M., Upton J.D., et al. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43 (1998) 830-836
29. Beutler E., Felitti V., Gelbart T., and Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 133 (2000) 329-337
30. de Valk B., Witlox R.S., van der Schouw Y.T., and Marx J.J. Biochemical expression of heterozygous hereditary hemochromatosis. Eur J Intern Med 11 (2000) 317-321
31. de Valk B., Addicks M.A., Gosriwatana I., Lu S., Hider R.C., and Marx J.M. Non-transferrin bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 30 (2000) 248-251
32. Pietrangelo A. Molecular insights into the pathogenesis of hereditary haemochromatosis. Gut 55 (2006) 564-568
33. Aruoma O.I., Bomford A., Polson R.J., and Halliwell B. Non-transferrin bound iron in plasma from haemochromatosis patients: effects of phlebotomy therapy. Blood 72 (1988) 1416-1419
34. Beutler E., Felitti V.J., Koziol J.A., Ho N.J., and Gelbart T. Penetrance of 845G-> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359 (2002) 211-218